Prescribing information

 

Prescribing information

Novartis’ Severe Asthma Masterclass is a multidisciplinary educational programme that has been running since 2008 and brings together expertise from across the UK to provide high-quality educational content to help improve your clinical practice in severe asthma.

Below you can view some of the presentations from our Masterclass meetings.

 

MASTERCLASS MEETING 2021
 

 

 

THE RIGHT BIOLOGIC FOR THE RIGHT PATIENT

Dr Hitasha Rupani explores decision making in severe asthma, including criteria for biologic choice, factors predicting good response, and efforts to reduce reliance on oral steroids.
 

 

 

 

NASAL POLYPS – WHAT ASTHMA DOCTORS NEED TO KNOW?

Dr Glenis Scadding discusses the symptoms, diagnosis and treatment of nasal polyps, with a focus on the link to asthma, and what future treatments could look like.
 

 

 

 

CORTICOSTEROIDS IN ASTHMA – AN ENDOCRINOLOGIST’S VIEW

Prof. Mark Gurnell examines the aetiology and clinical features of adrenal insufficiency, reasons for increased prevalence, and steroid sick day rules to keep patients safe.
 

 
 

MASTERCLASS WEBINAR 2020

 

 

 

COVID-19 AND SEVERE ASTHMA

In this 2020 webinar, Prof. Andrew Menzies-Gow discusses the lessons learned from the COVID-19 pandemic and how we can use these to improve severe asthma services in the future. This is followed by an expert panel discussion chaired by Dr Rob Niven and including Prof. Andrew Menzies-Gow, Rachel Stead and Dr Helen Hope.
 

 

 

MASTERCLASS MEETING 2019
 

 

 

ALLERGIC ASTHMA – DO WE GET IT RIGHT?

Speaking at the 2019 Severe Asthma Masterclass, Dr Robin Gore discusses recent progress in severe allergic asthma, our current understanding of the disease, and the importance of having the right tools to evaluate patients.
 

 

 

 

REFLUX AND ASTHMA – WHAT IS THE RELATIONSHIP?

Speaking at the 2019 Severe Asthma Masterclass, Prof. Alyn Morice discusses the relationship between oesophageal diseases, such as cough hypersensitivity syndrome, and the treatment of asthma.
 

 

 

 

ALLERGEN AVOIDANCE – ARE WE GETTING IT RIGHT?

Speaking at the 2019 Paediatric Severe Asthma Masterclass, Dr Clare Murray discusses the role of allergen exposure in children with asthma, and whether avoidance strategies can be used to improve asthma control.
 

 

 
Rate this content: 
No votes yet
UK | May 2021 | 126311
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]